Fish-oil dietary supplementation in patients with Raynaud's phenomenon: A double-blind, controlled, prospective study
- 31 December 1989
- journal article
- research article
- Published by Elsevier BV in The American Journal of Medicine
- Vol. 86 (2), 158-164
- https://doi.org/10.1016/0002-9343(89)90261-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cardiovascular Effects of n-3 Fatty AcidsThe New England Journal of Medicine, 1988
- Prevalence of Raynaud phenomenon in the general population: A preliminary study by questionnaireJournal of Chronic Diseases, 1986
- Effect of Dietary Enrichment with Eicosapentaenoic and Docosahexaenoic Acids on in Vitro Neutrophil and Monocyte Leukotriene Generation and Neutrophil FunctionThe New England Journal of Medicine, 1985
- Treatment of raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5‐HT2) receptorArthritis & Rheumatism, 1984
- Interleukin-1Clinical Infectious Diseases, 1984
- Thromboxane A3 (TXA3) is formed in human platelets after dietary eicosapentaenoic acid (C20:5ω3)Biochemical and Biophysical Research Communications, 1983
- Controlled Double-Blind Trial of Nifedipine in the Treatment of Raynaud's PhenomenonThe New England Journal of Medicine, 1983
- Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjectsAtherosclerosis, 1983
- Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil.Circulation, 1983
- Cold Hypersensitivity in Raynaud's PhenomenonCirculation, 1971